Director at Exelon (EXC) granted 3,720 restricted stock units
Rhea-AI Filing Summary
Exelon Corp director Matthew C. Rogers received an annual equity award of 3,720 restricted stock units for 2026 board service. These 2026 Directors Restricted Stock Units were granted at a $0.00 exercise price under the Exelon Long-term Incentive Plan and will fully vest and be settled in Exelon common shares on a 1-for-1 basis on April 28, 2027. The award will accumulate additional stock units through dividend reinvestment that vest with the underlying grant.
The filing also notes 739 deferred phantom share equivalents tied to Exelon common stock in a non-qualified deferred compensation plan. These phantom share equivalents are settled in cash on a 1-for-1 basis when Rogers’ service on Exelon’s board ends, rather than through open-market stock transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | 2026 Directors Restricted Stock Units | 3,720 | $0.00 | $0.00 |
| holding | Deferred phantom share equivalents | -- | -- | -- |
Footnotes (2)
- F1. Annual restricted stock unit (RSU) award subject to the Exelon Long-term Incentive Plan (LTIP) will fully vest and be settled in shares of Exelon common stock on a 1 for 1 basis. The award will accrue additional stock units through dividend reinvestment which will vest along with the underlying award.
- F2. Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors.
Key Figures
Key Terms
restricted stock unit (RSU) financial
Long-term Incentive Plan (LTIP) financial
non-qualified deferred compensation plan financial
AI-generated analysis. How Rhea-AI works. Not financial advice.